+39 02 610346.1 - info@newron.com

Investors and Media

Investors and Media

Newron Pharmaceuticals is headquartered in Bresso, Italy and its shares are listed on SIX Swiss Exchange under the ticker symbol NWRN. Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, including our latest share price, key financial data and presentations and webcasts.

 

Newron news see all

Newron Pharmaceuticals provides clinical and business update

 

Newron Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome

 

Newron Acknowledges Definitive Agreement Between US WorldMeds and Supernus Pharmaceuticals Regarding XADAGO® (safinamide)

Newron Receives Third Tranche from Financing Agreement with European Investment Bank (EIB)

 

Stock information

Download centre

Email alerts

 

 

 

 

 

Upcoming Eventssee all

11th Annual Jefferies 2020 Healthcare Conference

November 17-19, 2020 - virtual & London, UK

Deutsches Eigenkapitalforum Online

November, 16-18, 2020 

Investora Zürich 2020

September 23-24, 2020 – Zürich-Stettbach, Switzerland